MX2022004887A - Composiciones enriquecidas de acidos grasos poliinsaturados. - Google Patents

Composiciones enriquecidas de acidos grasos poliinsaturados.

Info

Publication number
MX2022004887A
MX2022004887A MX2022004887A MX2022004887A MX2022004887A MX 2022004887 A MX2022004887 A MX 2022004887A MX 2022004887 A MX2022004887 A MX 2022004887A MX 2022004887 A MX2022004887 A MX 2022004887A MX 2022004887 A MX2022004887 A MX 2022004887A
Authority
MX
Mexico
Prior art keywords
fatty acid
enriched
polyunsaturated fatty
acid compositions
long
Prior art date
Application number
MX2022004887A
Other languages
English (en)
Inventor
Stuart Littler
Original Assignee
Nuseed Nutritional Us Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuseed Nutritional Us Inc filed Critical Nuseed Nutritional Us Inc
Publication of MX2022004887A publication Critical patent/MX2022004887A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Las presentes modalidades proporcionan una composición lipídica de origen vegetal que comprende altas concentraciones de ácidos grasos omega-3 de cadena larga, típicamente como ésteres de ácidos grasos, que comprenden DPA, DTA, ETA o ETrA, opcionalmente con OA o ALA. Estas composiciones lipídicas enriquecidas tienen una estabilidad mejorada y ofrecen una fuente sostenible de estos ácidos grasos omega-3 de cadena larga. En algunas modalidades, estas composiciones lipídicas enriquecidas muestran una modulación mejorada de marcadores inflamatorios, tal como la inhibición de citocinas inflamatorias, y ofrecen valor nutricional o terapéutico.
MX2022004887A 2019-10-25 2020-10-23 Composiciones enriquecidas de acidos grasos poliinsaturados. MX2022004887A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962926239P 2019-10-25 2019-10-25
PCT/GB2020/052687 WO2021079142A1 (en) 2019-10-25 2020-10-23 Enriched polyunsaturated fatty acid compositions

Publications (1)

Publication Number Publication Date
MX2022004887A true MX2022004887A (es) 2022-08-04

Family

ID=73038258

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022004887A MX2022004887A (es) 2019-10-25 2020-10-23 Composiciones enriquecidas de acidos grasos poliinsaturados.

Country Status (15)

Country Link
US (1) US20220362199A1 (es)
EP (1) EP4048252A1 (es)
JP (1) JP2022554152A (es)
KR (1) KR20220088902A (es)
CN (1) CN114867476A (es)
AR (1) AR122331A1 (es)
AU (1) AU2020370081A1 (es)
BR (1) BR112022007695A2 (es)
CA (1) CA3155544A1 (es)
CL (1) CL2023002953A1 (es)
CO (1) CO2022005055A2 (es)
MX (1) MX2022004887A (es)
PE (1) PE20230178A1 (es)
TW (1) TW202128142A (es)
WO (1) WO2021079142A1 (es)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7807849B2 (en) 2004-04-22 2010-10-05 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
EP2120920A4 (en) * 2007-02-20 2011-06-15 Martek Biosciences Corp OXYLIPINES OF LONG-CHAIN MULTIPLE-UNSATURATED FATTY ACIDS AND METHOD FOR THEIR PREPARATION AND USE
BR122021003835B1 (pt) * 2008-11-18 2022-02-08 Grains Research And Development Corporation Polinucleotídeo isolado e/ou exógeno que não ocorre de forma natural, vetor compreendendo o referido polinucleotídeo e método de produção de óleo contendo ácidos graxos insaturados
SG11201408362SA (en) 2012-06-15 2015-01-29 Commw Scient Ind Res Org Production of long chain polyunsaturated fatty acids in plant cells
CN111154724B (zh) 2013-12-18 2024-02-06 联邦科学技术研究组织 包含二十二碳六烯酸的提取的植物脂质
WO2015196250A1 (en) 2014-06-27 2015-12-30 Commonwealth Scientific And Industrial Research Organisation Lipid comprising docosapentaenoic acid
EP4338586A2 (en) 2016-06-16 2024-03-20 Nuseed Nutritional Australia Pty Ltd Elite event canola ns-b50027-4
SG11201811219UA (en) 2016-06-16 2019-01-30 Nuseed Pty Ltd Inbred transgenic canola line ns-b50027-4 and seeds thereof

Also Published As

Publication number Publication date
EP4048252A1 (en) 2022-08-31
PE20230178A1 (es) 2023-02-01
AR122331A1 (es) 2022-08-31
AU2020370081A1 (en) 2022-06-02
JP2022554152A (ja) 2022-12-28
CL2023002953A1 (es) 2024-04-12
CN114867476A (zh) 2022-08-05
CO2022005055A2 (es) 2022-11-29
US20220362199A1 (en) 2022-11-17
CA3155544A1 (en) 2021-04-29
TW202128142A (zh) 2021-08-01
KR20220088902A (ko) 2022-06-28
BR112022007695A2 (pt) 2022-07-12
WO2021079142A1 (en) 2021-04-29

Similar Documents

Publication Publication Date Title
NZ721036A (en) Lipid comprising long chain polyunsaturated fatty acids
MY160520A (en) Bloom Retarding Fat
MX342216B (es) Composiciones de acidos grasos.
IN2014DN05640A (es)
GEP201606568B (en) Compositions for the treatment of neurologic disorders
MY175584A (en) Oxidatively stable polyunsaturated fatty acid containing oil
ES2376225T3 (es) Genes de elongasa y usos de los mismos.
WO2016040570A3 (en) Dietary emulsion formulations and methods for using the same
MX2020006759A (es) Composicion util como modificador de friccion.
CO2020013126A2 (es) Composiciones de ácidos grasos poliinsaturados enriquecidos con dha
MX2022004887A (es) Composiciones enriquecidas de acidos grasos poliinsaturados.
AR122837A1 (es) Composiciones de ácidos grasos poliinsaturados enriquecidos con dha
CL2020003279A1 (es) Composiciones de ácidos grasos poliinsaturados enriquecidos con ala
PH12017500738A1 (en) Feeding algae to cattle at low doses to produce high omega 3 levels in beef
MX2020013988A (es) Composiciones de acidos grasos poliinsaturados enriquecidos con dha.
MX2020013990A (es) Composiciones de acidos grasos poliinsaturados enriquecidos con dha.
MX2020013991A (es) Composiciones de acidos grasos poliinsaturados enriquecidos con dha.
EA202092556A1 (ru) Композиции полиненасыщенных жирных кислот, обогащенные дгк
SG11201811427YA (en) Dielectric fluid comprising fatty acid esters
NZ727514A (en) Lipid comprising docosapentaenoic acid
AR123741A2 (es) Aceite de semilla de brassica sp. o camelina sativa, composición, proceso para producir aceite de semilla extraído de brassica sp. o camelina sativa, harina de semilla obtenida de semilla de brassica sp. o camelina sativa, alimento para animales y método para producir alimento para animales
GB201319885D0 (en) Green coalescent agent composition containing fatty acid monoesters of vegetable oils with fusel oil alcohols